Total Non-Current Liabilities

$3.24B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$3.24Bperiod endingJun 30, 2026

VRTX Quarterly Total Non-Current Liabilities ($2.40M → $3.24B)

Quarterly total non-current liabilities

High-resolution chart · PNG

VRTX total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jun 30, 2001	346,633,000
Mar 31, 2001	346,966,000
Dec 31, 2000	357,269,000
Sep 30, 2000	348,121,000
Jun 30, 2000	178,619,000
Mar 31, 2000	179,155,000
Dec 31, 1999	4,693,000
Sep 30, 1999	5,200,000
Jun 30, 1999	5,800,000
Mar 31, 1999	6,400,000
Dec 31, 1998	7,000,000
Sep 30, 1998	7,600,000
Jun 30, 1998	6,900,000
Mar 31, 1998	6,200,000
Dec 31, 1997	5,900,000
Sep 30, 1997	5,400,000
Jun 30, 1997	5,400,000
Mar 31, 1997	5,300,000
Dec 31, 1996	5,600,000
Sep 30, 1996	4,400,000
Jun 30, 1996	4,500,000
Mar 31, 1996	4,400,000
Dec 31, 1995	4,900,000
Sep 30, 1995	4,900,000
Jun 30, 1995	5,000,000
Mar 31, 1995	5,000,000
Dec 31, 1994	4,700,000
Sep 30, 1994	4,600,000
Jun 30, 1994	4,400,000
Mar 31, 1994	3,800,000
Dec 31, 1993	4,200,000
Sep 30, 1993	4,000,000
Jun 30, 1993	3,800,000
Mar 31, 1993	3,400,000
Dec 31, 1992	3,200,000
Sep 30, 1992	3,200,000
Jun 30, 1992	3,000,000
Mar 31, 1992	2,300,000
Dec 31, 1991	2,200,000
Sep 30, 1991	2,300,000
Jun 30, 1991	2,500,000
Dec 31, 1990	2,400,000